Ignite Creation Date:
2025-12-24 @ 6:51 PM
Ignite Modification Date:
2025-12-30 @ 3:08 AM
Study NCT ID:
NCT02161757
Status:
COMPLETED
Last Update Posted:
2018-08-28
First Post:
2014-06-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Uncontrolled Asthma
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-06-13
Start Date Type:
ACTUAL
Primary Completion Date:
2017-02-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-07-18
Completion Date Type:
ACTUAL
First Submit Date:
2014-06-05
First Submit QC Date:
None
Study First Post Date:
2014-06-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-12-21
Results First Submit QC Date:
None
Results First Post Date:
2018-04-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-30
Last Update Post Date:
2018-08-28
Last Update Post Date Type:
ACTUAL